Valuation: Amgen Inc.

Market Cap 24TCr 3,61,21600Cr 20TCr 19TCr 18TCr 33TCr 22,79300Cr 33TCr 2,26400Cr 88TCr 11,50000Cr 90TCr 88TCr 38,08400Cr P/E 2026 *
28x
P/E 2027 * 25x
Enterprise Value 28TCr 4,23,89200Cr 24TCr 23TCr 21TCr 39TCr 26,74800Cr 39TCr 2,65700Cr 1,03400Cr 13,49500Cr 1,05400Cr 1,03100Cr 44,69200Cr EV / Sales 2026 *
7.21x
EV / Sales 2027 * 6.84x
Free-Float
99.77%
Yield 2026 *
2.28%
Yield 2027 * 2.41%
1 day-0.51%
1 week+5.18%
Current month+16.34%
1 month+17.73%
3 months+40.30%
6 months+25.71%
Current year+41.39%
1 week 22,800
Extreme 22800
23,810
1 month 19,830
Extreme 19830
23,810
Current year 15,920
Extreme 15920
23,810
1 year 12,320
Extreme 12320
23,810
3 years 6,246.17
Extreme 6246.166666
23,810
5 years 1,280.17
Extreme 1280.166666
23,810
10 years 273.67
Extreme 273.666666
23,810
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Director of Finance/CFO 67 01/01/2020
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Change 5-day change 1-year change 3-year change Capi.($)
-0.51%+5.18% - - 24TCr
-1.06%+0.65%+77.42%+122.82% 1,10000Cr
+0.04%+0.75%+53.10%+64.29% 66TCr
+0.48%+2.65%+28.06%+81.19% 47TCr
-0.71%+1.09%+43.29%+43.31% 37TCr
-0.48%+0.53%+26.18%+41.28% 30TCr
-1.20%+2.24%+3.77%+14.03% 26TCr
-0.36%+3.99%+53.31%+72.49% 24TCr
+0.17%+3.17%-11.97%-52.21% 21TCr
+1.38%+3.72%+30.33%+93.56% 18TCr
Average -0.08%+3.01%+33.72%+53.42% 42.25TCr
Weighted average by Cap. +0.02%+2.21%+45.78%+71.35%

Financials

2026 *2027 *
Net sales 3.89TCr 58,82900Cr 3.34TCr 3.13TCr 2.86TCr 5.39TCr 3,71200Cr 5.44TCr 37TCr 14TCr 1,87300Cr 15TCr 14TCr 6,20200Cr 4.02TCr 60,72800Cr 3.44TCr 3.23TCr 2.95TCr 5.56TCr 3,83200Cr 5.62TCr 38TCr 15TCr 1,93300Cr 15TCr 15TCr 6,40300Cr
Net income 859.76Cr 12,98900Cr 736.73Cr 690.32Cr 630.57Cr 1.19TCr 82TCr 1.2TCr 8.14TCr 3.17TCr 41TCr 3.23TCr 3.16TCr 1,36900Cr 939.37Cr 14,19200Cr 804.94Cr 754.25Cr 688.96Cr 1.3TCr 90TCr 1.31TCr 8.9TCr 3.46TCr 45TCr 3.53TCr 3.45TCr 1,49600Cr
Net Debt 4.15TCr 62,67700Cr 3.55TCr 3.33TCr 3.04TCr 5.74TCr 3,95500Cr 5.8TCr 39TCr 15TCr 1,99500Cr 16TCr 15TCr 6,60800Cr 3.58TCr 54,12900Cr 3.07TCr 2.88TCr 2.63TCr 4.96TCr 3,41600Cr 5.01TCr 34TCr 13TCr 1,72300Cr 13TCr 13TCr 5,70700Cr
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
25/26/25 ARS 23,570.00 -0.51% 1,335
24/26/24 ARS 23,690.00 +1.72% 1,694
21/26/21 ARS 23,290.00 +1.66% 1,465
20/26/20 ARS 22,910.00 -1.76% 1,254
19/26/19 ARS 23,320.00 +4.06% 2,811
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
442.24USD
Average target price
388.48USD
Spread / Average Target
-12.16%

Quarterly revenue - Rate of surprise